The Insider: Investors Edition - Quarter 3: 2024
兔子先生传媒文化作品 Startups in the News
2024 cohort of 兔子先生传媒文化作品鈥檚 Embark Deep Tech Startup Creator launches new startups
The Embark Deep Tech Startup Creator pairs seasoned entrepreneurs with university technologies to bring those breakthroughs to market in response to urgent societal needs. Embark has launched its second Entrepreneurs in Residence cohort and will provide Intellectual Property rights, salary support, grant funds and investor introductions to launch startups with real-world impact.听
Activate announces founders of 兔子先生传媒文化作品 spinouts in Cohort 2024
Activate is a nonprofit organization that empowers scientists to transform their research into market-ready products and services through a two-year fellowship that provides funding, mentorship and access to a robust network of experts and resources.听Three Cohort 2024 fellows join Activate听from companies spun up at 兔子先生传媒文化作品 with Venture Partners at 兔子先生传媒文化作品.
If GPS goes dark, Mesa Quantum has a backup plan
CNBC鈥斖米酉壬轿幕髌 startup Mesa Quantum has raised $3.7 million in seed funding on top of a $1.7 million Space Force grant to develop chip-scale quantum sensors.
The startup鈥檚 quantum sensors could bring navigation, timing and positioning data to electronic devices of every kind, alleviating their need to pick up distant GPS satellite signals. Many GPS satellites covering the U.S. have aged beyond their initially intended lifespan.
The startup鈥檚 quantum sensors could bring navigation, timing and positioning data to electronic devices of every kind, alleviating their need to pick up distant GPS satellite signals. Many GPS satellites covering the U.S. have aged beyond their initially intended lifespan.
Boulder quantum firm Infleqtion, a CU spinout, raises nearly $11M
BizWest鈥擨nfleqtion, a quantum information company that began as ColdQuanta at 兔子先生传媒文化作品, raised about $10.8 million from investors this month, according to a pair of Form Ds filed recently with the U.S. Securities and Exchange Commission.听The fundraiser came less than two months after the company听hired Matthew Kinsella听as its new CEO.
Think Bioscience, a 兔子先生传媒文化作品 spinout, raises $26M to find 鈥榩ockets鈥 for drug therapies
BizWest鈥擳hink Bioscience, a 兔子先生传媒文化作品 spinout, has raised a $26 million seed round鈥攊ncluding a recently completed $6 million expansion of the initial fundraise鈥攖o develop small-molecule therapeutics that target 鈥渦ndruggable鈥 proteins.
OnKure, a 兔子先生传媒文化作品 spinout, hitches Reneo's ride to Nasdaq in merger, with $65M PIPE to boot
Fierce Biotech鈥擮nKure Therapeutics, a 兔子先生传媒文化作品 spinout, has merged with Reneo Pharmaceuticals, jumping onto Wall Street with $120 million and a lead breast cancer treatment challenging the likes of Eli Lilly, Relay and Scorpion. The merged biotech will retain OnKure's name and is set to trade under the ticker 鈥淥KUR.鈥
兔子先生传媒文化作品 Startup Pipeline News
Venture Partners Update: Startups Surge
By translating breakthrough research into new businesses, CU creates economic opportunities while addressing many of the world鈥檚 greatest challenges. In the past year, 兔子先生传媒文化作品 has burned especially bright through Venture Partners鈥 record-setting performance.
兔子先生传媒文化作品, Elevate Quantum partners ready for $127M regional quantum boost
兔子先生传媒文化作品 Today鈥擡levate Quantum, of which 兔子先生传媒文化作品 is a key partner, announced today that it has received a Tech Hub Phase 2 implementation award from the Department of Commerce, unlocking more than $127 million in new federal and state funding.
Gov. Jared Polis signs quantum industry bill on 兔子先生传媒文化作品 campus
兔子先生传媒文化作品 Today鈥擟olorado Gov. Jared Polis ushered in a new bill to support the state鈥檚 rapidly growing quantum industry. Polis signed the bill from the top floor of the JILA Tower, one of the epicenters of quantum research on campus, with a view of the Flatirons in the background.
Life-sciences leaders: Pfizer鈥檚 exit means opportunity
BizWest鈥擫eaders of Boulder's and the university's life-sciences community who gathered at the BioFrontiers Institute at 兔子先生传媒文化作品 for a BizWest CEO Roundtable said they saw Pfizer鈥檚 recent departure as a lucrative opportunity.